Skip to main content
Glama

Tatoeba

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint false, covering safety. The description adds significant behavioral detail: cascading through multiple endpoints, graceful degradation when LEI/FIGI sources are unavailable, returning unresolved identifiers explicitly, and returning figi_candidates for ambiguous matches. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness2/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, extremely long run-on paragraph with numerous parentheticals and complex clauses. It is not front-loaded in a scannable way; the core purpose is buried among edge-case details. While comprehensive, it is not concise and would benefit from bullet points or shorter sentences.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with two types, multiple input formats, and complex behavior, the description covers everything: supported types, input formats, return behavior (including unresolved and candidates), degradation, and the replacement of manual lookups. No output schema exists, but the description adequately describes what the agent can expect.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and both parameters have descriptions, but the description adds substantial value. For 'value', it provides examples, explains the bond issuer-only rule, and warns against trailing security-class words. For 'type', it elaborates on the company subtype with multiple input formats and the drug subtype with RxNorm details, going well beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the verb 'resolve' and the resource: mapping a user-spoken name to canonical identifiers. It lists concrete example queries and supported types, making the purpose unambiguous and distinct from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID', giving a direct trigger. It also provides situational guidance, such as passing only the issuer name for bonds and not the full noun phrase, which helps the agent decide how to invoke the tool correctly.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Tatoeba toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3/5.0
Disambiguation2/5

Many tools have overlapping purposes (e.g., ask_pipeworx, ask_pipeworx_grounded, deep_research; multiple Polymarket tools). The memory tools (remember/recall/forget) are generic and could be confused with each other. Overall, there is significant ambiguity in tool selection.

Naming Consistency3/5

Most tool names use snake_case, but there is no strong verb_noun pattern. Some are simple nouns (languages, search) while others are verbs (forget, recall). The naming is readable but not highly consistent.

Tool Count1/5

With 34 tools, the set is far too large for a Tatoeba server. Only 4 tools (search, sentence, translations, languages) are actually related to Tatoeba; the rest cover unrelated domains (Pipeworx data, Polymarket, AI visibility). This is an extreme mismatch.

Completeness2/5

For the Tatoeba domain, the 4 tools cover basic functionality but lack operations like adding or editing sentences. The overwhelming presence of irrelevant tools makes the surface feel incomplete and disjointed for the server's stated purpose.

Resources